Preoperative Capecitabine and Concurrent Radiation for Borderline Resectable Pancreatic Cancer

ISSN： 1068-9265

Source： Annals of Surgical Oncology, Vol.18, Iss.3, 2011-03, pp. : 619-627

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy

By Varadhachary Gauri Tamm Eric Abbruzzese James Xiong Henry Crane Christopher Wang Huamin Lee Jeffrey Pisters Peter Evans Douglas Wolff Robert

Annals of Surgical Oncology, Vol. 13, Iss. 8, 2006-08 ,pp. : 1035-1046

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib with Concurrent Radiation for Newly Diagnosed Resectable Rectal Cancer

The Oncologist, Vol. 23, Iss. 1, 2018-01 ,pp. : 2-e5

John Wiley & Sons Inc

Access to resources Recommend Favorite

Defining Venous Involvement in Borderline Resectable Pancreatic Cancer

By Chun Yun

Annals of Surgical Oncology, Vol. 17, Iss. 11, 2010-11 ,pp. : 2832-2838

Springer Publishing Company

Access to resources Recommend Favorite

Borderline Resectable Pancreatic Cancer: A New Classification for an Old Challenge

By Talamonti Mark

Annals of Surgical Oncology, Vol. 13, Iss. 8, 2006-08 ,pp. : 1019-1020

Springer Publishing Company

Access to resources Recommend Favorite

Borderline Resectable Pancreatic Cancer: Definitions and the Importance of Multimodality Therapy

By Evans Douglas

Annals of Surgical Oncology, Vol. 17, Iss. 11, 2010-11 ,pp. : 2803-2805

Springer Publishing Company

Access to resources Recommend Favorite